These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1836068)

  • 1. [Atrial natriuretic factor in cardiovascular diseases].
    Nakamura M; Arakawa N; Hiramori K
    Kokyu To Junkan; 1991 Oct; 39(10):971-8. PubMed ID: 1836068
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial natriuretic peptide as angiotensin II antagonist. A new therapeutic principle?].
    Pfaffendorf M
    Med Monatsschr Pharm; 1992 Jun; 15(6):169-77. PubMed ID: 1535414
    [No Abstract]   [Full Text] [Related]  

  • 4. Atrial natriuretic factor: implications in congestive heart failure and hypertension.
    Burnett JC
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():41-6. PubMed ID: 2528638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormonal activity in congestive heart failure.
    Kubo SH
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S39-44. PubMed ID: 2136721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of body water regulation and the therapy--role of atrial natriuretic peptide in homeostasis of body water in heart failure].
    Knoshita M; Wada A
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1670-3. PubMed ID: 9410981
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of atrial natriuretic factor in cardiovascular physiopathology].
    Costa R; Marino A
    Clin Ter; 1991 Apr; 137(1):49-59. PubMed ID: 1828728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial natriuretic peptides reception and physiological effects].
    Mravian SR; Kalinin AP
    Klin Med (Mosk); 2002; 80(10):4-10. PubMed ID: 12471829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure and circulatory control peptides].
    Takeshita A
    Nihon Naika Gakkai Zasshi; 1994 Jan; 83(1):138-42. PubMed ID: 9132444
    [No Abstract]   [Full Text] [Related]  

  • 11. Sodium retention in heart failure.
    Cannon PJ
    Cardiol Clin; 1989 Feb; 7(1):49-62. PubMed ID: 2523241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial natriuretic peptide].
    Naruse M; Naruse K
    Kokyu To Junkan; 1989 Apr; 37(4):375-86. PubMed ID: 2544975
    [No Abstract]   [Full Text] [Related]  

  • 13. Atrial natriuretic factor: a new hormone with possible clinical importance.
    Zeigler DW; Zawada ET; Kauker ML
    S D J Med; 1987 Mar; 40(3):21-4. PubMed ID: 2951848
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R; Bonhomme MC; Diebold S
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of atrial natriuretic factor in chronic heart failure.
    McMurray J; Struthers AD
    Br J Hosp Med; 1988 Jul; 40(1):55-7. PubMed ID: 2971411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac afferents and neurohormonal activation in congestive heart failure.
    Davila DF; Donis JH; Bellabarba G; Torres A; Casado J; Mazzei de Davila C
    Med Hypotheses; 2000 Feb; 54(2):242-53. PubMed ID: 10790760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the clinical use of cardiac natriuretic peptides.
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G; ; ; ; ; ;
    Ital Heart J; 2005 May; 6(5):430-46. PubMed ID: 15934421
    [No Abstract]   [Full Text] [Related]  

  • 18. Natriuretic peptides and the management of heart failure.
    Calderone A
    Minerva Endocrinol; 2004 Sep; 29(3):113-27. PubMed ID: 15282444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human atrial natriuretic peptide: a secretory product of the heart and its significance for physiology and clinical practice].
    Vierhapper H; Waldhäusl W
    Wien Klin Wochenschr; 1987 Mar; 99(5):133-8. PubMed ID: 2953110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure.
    Yoshimura M; Yasue H; Ogawa H
    Can J Physiol Pharmacol; 2001 Aug; 79(8):730-5. PubMed ID: 11558682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.